Factors associated with smoking cessation and relapse in the Japanese smoking cessation treatment program: A prospective cohort study based on financial support in Suita City, Japan

被引:5
作者
Li, Meng [1 ]
Okamoto, Reiko [1 ]
Shirai, Fumie [2 ]
机构
[1] Osaka Univ, Grad Sch Med, Div Hlth Sci, Publ Hlth Nursing Lab, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Div Hlth Sci, Community Hlth Care Syst Sci Lab, Suita, Osaka, Japan
关键词
smoking cessation; Japan; treatment adherence; financial support; SELF-EFFICACY; VARENICLINE; THERAPY;
D O I
10.18332/tid/112154
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
INTRODUCTION The purpose of this study is to clarify the effect of providing financial support and factors associated with smoking cessation and relapse in the Japanese smoking cessation treatment (SCT) program based on financial support. METHODS A prospective cohort study was conducted at the smoking cessation outpatients of hospitals or clinics in Suita City, Japan from May 2017 to September 2018. In all, 153 participants were recruited and received standardized treatment based on the SCT program. Participants were required to answer four questionnaires and register for the financial support program. Chi-squared test, Fisher's exact test, non-paired t-test and log-binomial regression analysis were used to analyze the data. RESULTS Of the 153 participants, 140 participants completed a 12-week treatment and the completion rate was 91.5%. There were no factors significantly associated with smoking cessation and relapse (p<0.05). However, male, cigarettes smoked per day, having present diseases, having previous abstinence, living with family, cohabitation with smokers, desire to smoke at the start of treatment, self-efficacy at the start of treatment, desire to smoke at 4 weeks and self-efficacy at 4 weeks showed statistically significant odds ratio for success of smoking cessation. Similarly at 12 weeks, male, age at smoking initiation, cigarettes smoked per day, having previous abstinence, living with family, cohabitation with smokers, desire to smoke, self-efficacy and depression disorders showed statistically significant odds ratio for smoking relapse. In addition, the rate of abstainers using varenicline was 68.60%, which was higher than abstainers using nicotine patch (55.60%) and the relapse rate of participants using nicotine patch was 100.00%, significantly higher than for relapsers using varenicline (45.80%). CONCLUSIONS Further study is expected to clarify the effect of providing financial support and the factors associated with smoking cessation and relapse in the SCT program based on financial support.
引用
收藏
页数:12
相关论文
共 34 条
[1]  
[Anonymous], 2017, WHO Report on the Global Tobacco Epidemic, 2017: Monitoring Tobacco Use and Prevention Policies
[2]  
[Anonymous], 2015, HLTH EVALUATION PROM, DOI DOI 10.7143/JHEP.42.385
[3]   Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks A Randomized Clinical Trial [J].
Baker, Timothy B. ;
Piper, Megan E. ;
Stein, James H. ;
Smith, Stevens S. ;
Bolt, Daniel M. ;
Fraser, David L. ;
Fiore, Michael C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (04) :371-379
[4]   Self-Efficacy and Smoking Cessation: A Meta-Analysis [J].
Gwaltney, Chad J. ;
Metrik, Jane ;
Kahler, Christopher W. ;
Shiffman, Saul .
PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2009, 23 (01) :56-66
[5]   Dynamic self-efficacy and outcome expectancies: Prediction of smoking lapse and relapse [J].
Gwaltney, CJ ;
Shiffman, S ;
Balabanis, MH ;
Paty, JA .
JOURNAL OF ABNORMAL PSYCHOLOGY, 2005, 114 (04) :661-675
[6]   Adult Mortality Attributable to Preventable Risk Factors for Non-Communicable Diseases and Injuries in Japan: A Comparative Risk Assessment [J].
Ikeda, Nayu ;
Inoue, Manami ;
Iso, Hiroyasu ;
Ikeda, Shunya ;
Satoh, Toshihiko ;
Noda, Mitsuhiko ;
Mizoue, Tetsuya ;
Imano, Hironori ;
Saito, Eiko ;
Katanoda, Kota ;
Sobue, Tomotaka ;
Tsugane, Shoichiro ;
Naghavi, Mohsen ;
Ezzati, Majid ;
Shibuya, Kenji .
PLOS MEDICINE, 2012, 9 (01)
[7]   Twelve Weeks of Successful Smoking Cessation Therapy with Varenicline Reduces Spirometric Lung Age [J].
Iwaoka, Masahiko ;
Tsuji, Takeshi .
INTERNAL MEDICINE, 2016, 55 (17) :2387-2392
[8]   Twelve weeks of smoking cessation therapy with varenicline increases the serum levels of apolipoprotein A-I only in the success group [J].
Iwaoka, Masahiko ;
Shimamura, Hiromasa ;
Tsuji, Takeshi ;
Kugiyama, Kiyotaka .
JOURNAL OF CARDIOLOGY, 2014, 64 (3-4) :318-323
[9]   The status and future directions of comprehensive tobacco control policies for the 2020 Tokyo Olympic Games: A review [J].
Li, Meng ;
Tada, Aoki ;
Kiya, Misaki ;
Okamoto, Reiko .
TOBACCO INDUCED DISEASES, 2019, 17
[10]  
MIYAGI O, 2012, J HUMAN ARTS SCI, V0008, P00091, DOI DOI 10.11427/JHAS.8.91